Stereotactic biopsy vs. surgical resection in patient with diffuse low grade gliomas. Influence of inital management strategies on surival. A retrospective study.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00009264

Enrollment

141

Registered

2015-09-01

Start date

2015-02-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

D33 C71

Interventions

Group 1: Assessment of Overall Survival (OS) of all adult patients with a first histological diagnosis of diffuse low grade gliomas (DLGG) who were treated by either stereotactic biopsy or resection a

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: All patients 18 years or older with a first histological diagnosis of a supratentorial DLGG (WHO°II) from either a stereotactic biopsy or a neurosurgical resection between 2004 and 2012 in the Department of Neurosurgery or the Department of Stereotactic and Functional Neurosurgery of the University Medical Center Freiburg.

Exclusion criteria

Exclusion criteria: Patients with evidence for a gemistocytic histology.

Design outcomes

Primary

Measure	Time frame
Overall survival (OS) from the date of the first histological diagnosis until death or November 30, 2014 or lost to follow-up, whatever is earlier.	—

Secondary

Measure	Time frame
Operative morbidity and mortality	—

Countries

Germany

Contacts

Public ContactPeter Reinacher

Universitätsklinikum Freiburg

peter.reinacher@uniklinik-freiburg.de+49 761 270 50680

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026